CEP-26401 (Irdabisant), a Potent and Selective Histamine H3 Receptor Antagonist/Inverse Agonist with Cognition-Enhancing and Wake-Promoting Activities-Reference-Cited by-同舟云学术

CEP-26401 (Irdabisant), a Potent and Selective Histamine H3 Receptor Antagonist/Inverse Agonist with Cognition-Enhancing and Wake-Promoting Activities

Published:2011-10-14 Issue:1 Volume:340 Page:124-133
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Raddatz Rita,Hudkins Robert L.,Mathiasen Joanne R.,Gruner John A.,Flood Dorothy G.,Aimone Lisa D.,Le Siyuan,Schaffhauser Hervé,Duzic Emir,Gasior Maciej,Bozyczko-Coyne Donna,Marino Michael J.,Ator Mark A.,Bacon Edward R.,Mallamo John P.,Williams Michael

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Highly potent and selective ligands for histamine H3-receptors

2. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

3. Histamine H3 Receptor as a Drug Discovery Target

4. Histamine H3 receptor antagonists: From target identification to drug leads

5. Discovery of Histamine H3 Antagonists for the Treatment of Cognitive Disorders and Alzheimer's Disease

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder;Pharmaceuticals;2024-06-25

2. Pyridazinones: A versatile scaffold in the development of potential target‐based novel anticancer agents;Journal of Heterocyclic Chemistry;2022-11-02

3. Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives;Frontiers in Pharmacology;2022-10-12

4. Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep–Wake Cycle Disorder;Frontiers in Pharmacology;2022-06-01

5. Animal Models of Tic Disorders;Tourette Syndrome;2022-04